AKB MEDICALS LTD
Opportunity 74/100 (strong), bankability 75/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: medium (78/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Signals from accounts
Derived from iXBRL accounts · FRS 105 (micro)Key financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · FRS 105 (micro)| Metric | 2025-02-28 | 2024-02-28 |
|---|---|---|
| Total assets | £-12.2k | £-11.9k |
| Current assets | £190 | £15.5k |
| Net assets | £-12.2k | £-11.9k |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 1 confirmation-statement
- • 1 accounts
Corporate timeline (23 events)Click to expand
- 2026-02-27📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2024-11-28📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2023-11-30📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2023-02-09📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2022-02-28📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2021-02-26📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2019-11-28📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2018-11-30📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2017-07-06📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2017-04-26📄change-account-reference-date-company-previous-shortenedaccounts · AA01
- 2016-12-16📄accounts-with-accounts-type-dormantaccounts · AA
- 2016-11-17📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2016-11-17📄appoint-person-director-company-with-name-dateofficers · AP01
- 2016-11-17📄termination-director-company-with-name-termination-dateofficers · TM01
- 2016-11-17📄termination-director-company-with-name-termination-dateofficers · TM01
- 2016-11-15➕MISTRY, Nisha appointeddirector
- 2016-11-15➖BAGGA, Arun, Dr resigneddirector
- 2016-11-15➕BAGGA, Madan Gopal appointeddirector
- 2016-11-15➖BAGGA, Madan Gopal resigneddirector
- 2016-11-15➕BAGGA, Suraj Kanta appointeddirector
- 2016-11-15➖BAGGA, Suraj Kanta resigneddirector
- 2015-03-18🏢Company incorporatedAs AKB MEDICALS LTD
- 2015-03-18➕BAGGA, Arun, Dr appointeddirector
Owner dependency
Material founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.
- +Sole director: Only one active director — all governance concentrated on one person.
Succession & seller-readiness
Some succession indicators present. Worth watching; approach if sector/strategy fits.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
Red flags
cleanShareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Miss Nisha Mistry Individual · British · DOB 04/1980 · age 46 | 75–100% | — | 75-100% shares | 06/04/2016 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Healthcare & medical · SW postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| ADVANCED LONDON SPINE SURGERY LIMITED→ 10788595 · est 2017 · no financials extracted | — | — | — | — | 8y | — | — |
| AEQUILIBRIUM LONDON LTD→ 14190988 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| AGE UK LAMBETH→ 03252067 · est 1996 · no financials extracted | — | — | — | — | 29y | — | — |
| AHMADIYYA MUSLIM JAMAAT INTERNATIONAL→ 04785585 · est 2003 · no financials extracted | — | — | — | — | 22y | — | — |
| AHS MED LTD→ 08773163 · est 2013 · no financials extracted | — | — | — | — | 12y | — | — |
| AHTHAVANN VELU LTD→ 10438364 · est 2016 · no financials extracted | — | — | — | — | 9y | — | — |
| AIRAH CARE LIMITED→ 14303533 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| AK MEDICAL AESTHETICS LTD→ 17124404 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
| AKAEME HEALTHCARE LIMITED→ 14481807 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| AKAJA LTD→ 09567664 · est 2015 · no financials extracted | — | — | — | — | 10y | — | — |
| AKANINYENE LTD→ 14162811 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| AKERMAN LIMITED→ 04274173 · est 2001 · no financials extracted | — | — | — | — | 24y | — | — |
7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (1 active · 3 resigned)
Click a director name to see their full track record across all companies.